A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Tata India Pharma & HealthCare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
89.25% ↑
NAV (₹) on 27 Mar 2026
33.41
1 Day NAV Change
-1.02%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum ... Read more
NAV History
Fund Details
Min. SIP Amount
₹150
Inception Date
04 Dec 2015
Min. Lumpsum Amount
₹ 5,000
Fund Age
10 Yrs
AUM
₹ 1,300.81 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.69%
Scheme Type
Open Ended
Exit Load
0.25%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,300.81 Cr
Equity
188.39%
Money Market & Cash
11.61%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 58.69% |
| Hospitals & Medical Services | 35.52% |
| Agro Chemicals/Pesticides | 3.33% |
| Cash | 2.24% |
| CBLO/Reverse Repo | 0.20% |
| Medical Equipment & Accessories | 0.02% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 9.66% | ₹ 125.61 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD. | 6.78% | ₹ 88.23 | Hospitals & Medical Services |
| DIVI LABORATORIES LTD. | 5.94% | ₹ 77.29 | Pharmaceuticals |
| ABBOTT INDIA LTD. | 5.60% | ₹ 72.83 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD. | 5.04% | ₹ 65.61 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.00% | ₹ 65.04 | Hospitals & Medical Services |
| CIPLA LTD. | 4.55% | ₹ 59.16 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD. | 3.83% | ₹ 49.84 | Hospitals & Medical Services |
| MANKIND PHARMA LTD | 3.40% | ₹ 44.27 | Pharmaceuticals |
| BAYER CROPSCIENCE LTD. | 3.33% | ₹ 43.37 | Agro Chemicals/Pesticides |
| FORTIS HEALTHCARE LTD. | 3.27% | ₹ 42.56 | Hospitals & Medical Services |
| SAI LIFE SCIENCES LTD | 3.25% | ₹ 42.33 | Pharmaceuticals |
| J.B.CHEMICALS & PHARMACEUTICALS LTD. | 3.21% | ₹ 41.71 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD. | 3.13% | ₹ 40.68 | Hospitals & Medical Services |
| LUPIN LTD. | 3.08% | ₹ 40.11 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 3.04% | ₹ 39.60 | Pharmaceuticals |
| DR. LAL PATH LABS LTD. | 2.71% | ₹ 35.28 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD. | 2.64% | ₹ 34.36 | Hospitals & Medical Services |
| SYNGENE INTERNATIONAL LTD. | 2.39% | ₹ 31.15 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 2.24% | ₹ 28.68 | Others |
| ALKEM LABORATORIES LTD. | 2.15% | ₹ 28.01 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 2.06% | ₹ 26.77 | Pharmaceuticals |
| NEULAND LABORATORIES LTD. | 2.00% | ₹ 25.99 | Pharmaceuticals |
| SANOFI INDIA LTD. | 1.99% | ₹ 25.88 | Pharmaceuticals |
| FDC LTD. | 1.82% | ₹ 23.64 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 1.82% | ₹ 23.72 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD. | 1.55% | ₹ 20.17 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD. | 1.50% | ₹ 19.57 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD. | 1.07% | ₹ 13.90 | Pharmaceuticals |
| CORONA REMEDIES LTD | 0.99% | ₹ 12.93 | Pharmaceuticals |
| HIKAL LTD. | 0.60% | ₹ 7.75 | Pharmaceuticals |
| REPO | 0.20% | ₹ 2.61 | Others |
| JUBILANT PHARMOVA LTD | 0.07% | ₹ 0.93 | Pharmaceuticals |
| DR. AGARWALS HEALTH CARE LTD. | 0.07% | ₹ 0.91 | Hospitals & Medical Services |
| LAXMI DENTAL LIMITED | 0.02% | ₹ 0.28 | Medical Equipment & Accessories |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -3.87% | 1.24% | 8.72% | 23.69% |
| Category returns | -6.96% | 1.07% | 6.24% | 23.23% |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
AMC Details
Name
Tata Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Prathit Bhobe
CIO
Mr. Rahul Singh
Type
Pvt.Sector-Indian
Address
1903, B-Wing, Parinee Crescenzo,
G-Block, Bandra Kurla Complex,
Bandra East, Mumbai, Maharashtra, India - 400051
Website
http://www.tatamutualfund.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Quantum ESG Best In Class Strategy Fund
Diversified
Regular
|
₹20.89 | -6.99% | 32.30% | 47.42% | ₹95 | 2.18% |
Very High
|
|
DSP Quant Fund
Largecap
Regular
|
₹19.83 | -1.18% | 32.19% | 43.66% | ₹838 | 1.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹180.99 | -9.58% | 32.10% | 72.24% | ₹4,273 | 1.92% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Diversified
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Sector
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
Top Funds from Tata Asset Management Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan - Growth
Hybrid
Regular
|
₹56.36 | 6.88% | 32.55% | 47.04% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Childrens Fund - Direct Plan
Diversified
Direct
|
₹58.24 | -7.83% | 32.11% | 61.34% | ₹344 | 1.99% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹392.25 | -5.16% | 31.65% | 66.56% | ₹3,715 | 0.71% |
Very High
|
|
Tata BSE Sensex Index Fund - Direct Plan
Index
Direct
|
₹195.89 | -4.46% | 30.89% | 55.77% | ₹399 | 0.29% |
Very High
|
|
Tata Large & Mid Cap Fund - Regular Plan
Diversified
Regular
|
₹71.62 | -9.88% | 30.71% | 61.20% | ₹8,143 | 1.78% |
Very High
|
|
Tata Large & Mid Cap Fund - Regular Plan
Diversified
Regular
|
₹71.62 | -9.88% | 30.71% | 61.20% | ₹8,143 | 1.78% |
Very High
|
FAQs
What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹33.41 as of 27 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹1,300.81 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
Tata India Pharma & HealthCare Fund - Direct Plan Growth has delivered returns of 1.24% (1 Year), 23.69% (3 Year), 16.37% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
Tata India Pharma & HealthCare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work? -
Are Retirement Mutual Funds The Right Choice For Long-Term Investment Planning?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+